Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 4Differentiated Thyroid Cancer 2Adenoma, Islet Cell 2Tuberous Sclerosis 1Thyroid Cancer, Papillary 1Pituitary Neoplasms 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Insulinoma 1Hyperinsulinism 1Growth Hormone-Secreting Pituitary Adenoma 1Gastroenteropancreatic Neuroendocrine Tumors 1Congenital Hyperinsulinism 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Carcinoid Tumor 1Advanced Extrapulmonary Neuroendocrine Cancer 1Adenocarcinoma, Follicular 1Acromegaly 1

Interventions

exemestane 1Injections 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tuberous Sclerosis × Injections × Endocrine × Clear all
NCT07369505 2026-01-27

Sapu003 in Advanced mTOR-sensitive Solid Tumors

SAPU NANO (US) LLC

Phase 1 Recruiting
27 enrolled
EndocrineGastrointestinalGenitourinaryNET

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Tuberous Sclerosis, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡